jrnl9358

Publication Venue For

  • Correction: Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation (Oncogene, (2020), 39, 9, (1846-1859), 10.1038/s41388-019-1104-z).  39:2027. 2020
  • Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation.  39:1846-1859. 2020
  • Context-dependent activation of SIRT3 is necessary for anchorage-independent survival and metastasis of ovarian cancer cells.  39:1619-1633. 2020
  • Correction: EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway (Oncogene, (2020), 39, 5, (1041-1048), 10.1038/s41388-019-1036-7).  39:1165. 2020
  • EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.  39:1041-1048. 2020
  • Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression 2020
  • Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance.  38:6159-6171. 2019
  • MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer.  38:4820-4834. 2019
  • Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.  38:4496-4511. 2019
  • Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.  38:2241-2262. 2019
  • JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity.  38:980-997. 2019
  • Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer.  37:4792-4808. 2018
  • Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors.  37:1610-1623. 2018
  • Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression.  36:4014-4024. 2017
  • KLF6 depletion promotes NF-κB signaling in glioblastoma.  36:3562-3575. 2017
  • LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism.  36:1245-1255. 2017
  • MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer.  35:6330-6340. 2016
  • SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.  35:5641-5652. 2016
  • Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.  35:2087-2097. 2016
  • Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.  35:1468-1474. 2016
  • The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models.  35:833-845. 2016
  • Erratum: Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation (Oncogene (2015) 34 (3881) DOI:10.1038/onc.2015.204).  34:3881. 2015
  • Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.  34:3770-3779. 2015
  • Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation.  34:3076-3084. 2015
  • β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids..  34:2297-2308. 2015
  • ICAM-2 confers a non-metastatic phenotype in neuroblastoma cells by interaction with α-actinin.  34:1553-1562. 2015
  • Phosphodiesterase 10A: A novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity.  34:1499-1509. 2015
  • ASC deficiency suppresses proliferation and prevents medulloblastoma incidence..  34:394-402. 2015
  • PTEN functions as a melanoma tumor suppressor by promoting host immune response.  33:4632-4642. 2014
  • Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling.  33:2620-2628. 2014
  • MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.  33:1736-1742. 2014
  • Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.  33:1181-1189. 2014
  • Soluble E-cadherin: A critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling.  33:225-235. 2014
  • ΔNp63α regulates Erk signaling via MKP3 to inhibit cancer metastasis.  33:212-224. 2014
  • Stabilization of HIF-2α through redox regulation of mTORC2 activation and initiation of mRNA translation.  32:3147-3155. 2013
  • Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation.  32:2304-2314. 2013
  • PI3K regulation of the SKP-2/p27 axis through mTORC2.  32:2027-2036. 2013
  • TβRIII/β-arrestin2 regulates integrin α5β1 trafficking, function, and localization in epithelial cells.  32:1416-1427. 2013
  • SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells.  32:589-598. 2013
  • MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4.  32:462-470. 2013
  • A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40kDa vasculostatin from tumor suppressor BAI1.  31:5144-5152. 2012
  • Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs.  31:4979-4986. 2012
  • Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair.  31:4718-4724. 2012
  • DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin.  31:4472-4483. 2012
  • Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61.  31:3370-3380. 2012
  • Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer..  31:2521-2534. 2012
  • A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.  31:322-332. 2012
  • The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma.  30:4339-4349. 2011
  • MiR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT.  30:3440-3453. 2011
  • NF-κB addiction and its role in cancer: One size does not fit all.  30:1615-1630. 2011
  • Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.  30:896-906. 2011
  • The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.  29:5370-5380. 2010
  • Increased cell migration and plasticity in Nrf2-deficient cancer cell lines.  29:3703-3714. 2010
  • The prolyl isomerase Pin1 regulates the NF-B signaling pathway and interleukin-8 expression in glioblastoma.  28:3735-3745. 2009
  • Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma.  28:2513-2523. 2009
  • Repression of E-cadherin by the polycomb group protein EZH2 in cancer.  27:7274-7284. 2008
  • Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.  27:7192-7200. 2008
  • Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.  27:4034-4043. 2008
  • Regulation of normal cell cycle progression by flavin-containing oxidases.  27:20-31. 2008
  • Erratum: HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells (Oncogene (2006) 25, (1721-1732) DOI: 10.1038/sj.onc.1209199).  26:7282. 2007
  • Inactivation of the ubiquitin conjugating enzyme UBE2Q2 causes a prophase arrest and enhanced apoptosis in response to microtubule inhibiting agents.  26:6509-6517. 2007
  • Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.  26:4084-4094. 2007
  • A novel antioxidant 3-O-Caffeoyl-1-methylquinic acid enhances ultraviolet A-mediated apoptosis in immortalized HaCaT keratinocytes via Sp1-dependent transcriptional activation of p21WAF1/Cip1.  26:3559-3571. 2007
  • Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity.  26:3431-3439. 2007
  • Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.  26:2563-2573. 2007
  • Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-κB activation in normal human bronchial epithelial cells.  26:673-682. 2007
  • Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.  25:7565-7576. 2006
  • Proteomic identification of the wt-p53-regulated tumor cell secretome.  25:7650-7661. 2006
  • Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death.  25:4370-4375. 2006
  • HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells.  25:1721-1732. 2006
  • Unique aspects of mda-7/IL-24 antitumor bystander activity: Establishing a role for secretion of MDA-7/IL-24 protein by normal cells.  24:7552-7566. 2005
  • Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors.  24:5589-5605. 2005
  • Expression of DLK1 in hematopoietic cells results in inhibition of differentiation and proliferation.  24:4472-4476. 2005
  • Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor.  24:3632-3642. 2005
  • HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.  24:3110-3120. 2005
  • Induction of KLF4 in basal keratinocytes blocks the proliferation- differentiation switch and initiates squamous epithelial dysplasia.  24:1491-1500. 2005
  • Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells.  23:5513-5522. 2004
  • Lupeol modulates NF-κB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice.  23:5203-5214. 2004
  • Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin.  23:5151-5160. 2004
  • Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression.  23:4315-4329. 2004
  • Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappaB and induction of apoptosis.  23:2507-2522. 2004
  • Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.  23:2330-2338. 2004
  • Regulation of apoptosis proteins in cancer cells by ubiquitin.  23:2009-2015. 2004
  • A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance.  23:744-752. 2004
  • Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer.  23:100-108. 2004
  • Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice.  22:9254-9264. 2003
  • Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells.  22:8117-8124. 2003
  • Tumor suppressor p53 inhibits transcriptional activation of invasion gene thromboxane synthase mediated by the proto-oncogenic factor ets-1.  22:7716-7727. 2003
  • Ras oncogene directs expression of a differentially sialylated, functionally altered β1 integrin.  22:7137-7145. 2003
  • p73 can suppress the proliferation of cells that express mutant p53.  22:5481-5495. 2003
  • Characterization of p73 functional domains necessary for transactivation and growth suppression.  22:4333-4347. 2003
  • A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy.  22:2065-2072. 2003
  • Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway.  22:2034-2044. 2003
  • Inhibition of ultraviolet B-mediated activation of nuclear factor κB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate.  22:1035-1044. 2003
  • Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.  21:4212-4219. 2002
  • Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells.  21:3727-3738. 2002
  • Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells..  21:3727-3738. 2002
  • The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells.  21:3232-3240. 2002
  • The leukemia-associated transcription repressor aml1/mds1/evi1 requires ctbp to induce abnormal growth and differentiation of murine hematopoietic cells.  21:3232-3240. 2002
  • Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor.  21:148-152. 2002
  • Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5′ end of the BRCA1 gene.  21:4171-4175. 2002
  • The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis.  21:7195-7204. 2002
  • TGF-β1 up-regulates paxillin protein expression in malignant astrocytoma cells: Requirement for a fibronectin substrate.  20:7976-7986. 2001
  • HNPCC mutations in the human DNA mismatch repair gene hMLH1 influence assembly of hMutLα and hMLH1-hEXO1 complexes.  20:3590-3595. 2001
  • Quantitative real-time PCR does not show selective targeting of p14ARF but concomitant inactivation of both p16INK4A and p14ARF in 105 human primary gliomas.  20:1103-1109. 2001
  • Transcriptional regulation of the human osteopontin promoter: Functional analysis and DNA-protein interactions.  19:5801-5809. 2000
  • The Src/Csk regulatory circuit arose early in metazoan evolution.  19:3925-3930. 2000
  • p53 gene mutation and ink4a-arf-deletion appear to be two mutually exclusive events in human glioblastoma.  19:3816-3822. 2000
  • The p44(S10) locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma.  19:1419-1427. 2000
  • Increased protein kinase Cδ in mammary tumor cells: Relationship to transformation and metastatic progression.  18:6748-6757. 1999
  • Mitochondrial DNA determines the cellular response to cancer therapeutic agents.  18:6641-6646. 1999
  • Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes.  18:6469-6476. 1999
  • Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor.  18:5870-5878. 1999
  • Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFα expression in transgenic mice.  18:3593-3607. 1999
  • Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma.  18:1447-1456. 1999
  • Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.  18:365-375. 1999
  • Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes.  17:2027-2038. 1998
  • Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.  16:3331-3335. 1998
  • Genetic instability leads to loss of both p53 alleles in a human glioblastoma.  16:321-326. 1998
  • New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26.  15:997-1000. 1997
  • Novel BRCA1 mutations and more frequent intron-20 alteration found among 236 women from Western Poland.  15:1773-1779. 1997
  • The role of p27(Kip1) in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells.  14:2111-2122. 1997
  • The tetratricopeptide repeat containing Tg737 gene is a liver neoplasia tumor suppressor gene.  15:1797-1803. 1997
  • ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block.  13:2225-2234. 1996
  • Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: Activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q.  13:1249-1257. 1996
  • The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.  12:265-275. 1996
  • The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.  10:1855-1864. 1995
  • Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity.  9. 1994
  • Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity.  9:255-262. 1994
  • Recombinant retroviruses encoding human papillomavirus type 18 E6 and E7 genes stimulate proliferation and delay differentiation of human keratinocytes early after infection.  7:619-626. 1992
  • Evidence for tau expression in cells of monocyte lineage and its in vitro phosphorylation by v-fms kinase.  6:1085-1087. 1991
  • In vitro and in vivo growth control of transformed lymphoid cells expressing plasma membrane galactosyltransferase.  4:1337-1344. 1989